NEO
NEO
NASDAQ · Health Care

Neogenomics Inc

$18.38
+0.60 (+3.37%)
As of Oct 3, 1:47 AM ET ·
Financial Highlights (FY 2026)
Revenue
705.65M
Net Income
-104,806,553
Gross Margin
43.2%
Profit Margin
-14.9%
Rev Growth
+12.6%
D/E Ratio
0.41
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 43.2% 43.2% 50.1% 50.1%
Operating Margin -15.9% -14.3% 8.8% 8.7%
Profit Margin -14.9% -14.1% 7.4% 6.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 705.65M 626.79M 759.46M 804.45M
Gross Profit 304.91M 270.84M 380.80M 403.36M
Operating Income -112,409,290 -89,863,529 67.00M 69.80M
Net Income -104,806,553 -83,785,661 56.53M 50.19M
Gross Margin 43.2% 43.2% 50.1% 50.1%
Operating Margin -15.9% -14.3% 8.8% 8.7%
Profit Margin -14.9% -14.1% 7.4% 6.2%
Rev Growth +12.6% +12.6% -7.8% -8.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 331.31M 331.31M 99.64M 90.17M
Total Equity 810.84M 810.84M 945.36M 961.54M
D/E Ratio 0.41 0.41 0.11 0.09
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -77,762,908 -65,619,792 95.37M 98.54M
Free Cash Flow — — 21.30M 34.74M